Randomized phase II study of recombinant human endostatin combined with definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.

Jiahua Lv, Junchao Wang, Xiaorong Deng et al.|Journal of Clinical Oncology|2015

Cited by 4